Machine learning for prediction of all-cause mortality after transcatheter aortic valve implantation

Author:

Kwiecinski Jacek12,Dabrowski Maciej1ORCID,Nombela-Franco Luis3ORCID,Grodecki Kajetan4,Pieszko Konrad25,Chmielak Zbigniew1,Pylko Anna1,Hennessey Breda3,Kalinczuk Lukasz1ORCID,Tirado-Conte Gabriela3,Rymuza Bartosz4,Kochman Janusz4,Opolski Maksymilian P1,Huczek Zenon4,Dweck Marc R6,Dey Damini2ORCID,Jimenez-Quevedo Pilar3,Slomka Piotr2ORCID,Witkowski Adam1ORCID

Affiliation:

1. Department of Interventional Cardiology and Angiology, Institute of Cardiology , Warsaw , Poland

2. Departments of Medicine (Division of Artificial Intelligence in Medicine) and Biomedical Sciences, Cedars-Sinai Medical Center , 8700 Beverly Blvd, Metro 203, Los Angeles, CA 90048 , USA

3. Cardiovascular Institute, Hospital Clinico San Carlos, IdISSC , Madrid , Spain

4. 1st Department of Cardiology, Medical University of Warsaw , Warsaw , Poland

5. Department of Interventional Cardiology and Cardiac Surgery, University of Zielona Gora, Zielona Gora, Poland

6. Centre for Cardiovascular Science, University of Edinburgh , Edinburgh , UK

Abstract

Abstract Aims Prediction of adverse events in mid-term follow-up after transcatheter aortic valve implantation (TAVI) is challenging. We sought to develop and validate a machine learning model for prediction of 1-year all-cause mortality in patients who underwent TAVI and were discharged following the index procedure. Methods and results The model was developed on data of patients who underwent TAVI at a high-volume centre between January 2013 and March 2019. Machine learning by extreme gradient boosting was trained and tested with repeated 10-fold hold-out testing using 34 pre- and 25 peri-procedural clinical variables. External validation was performed on unseen data from two other independent high-volume TAVI centres. Six hundred four patients (43% men, 81 ± 5 years old, EuroSCORE II 4.8 [3.0–6.3]%) in the derivation and 823 patients (46% men, 82 ± 5 years old, EuroSCORE II 4.7 [2.9–6.0]%) in the validation cohort underwent TAVI and were discharged home following the index procedure. Over the 12 months of follow-up, 68 (11%) and 95 (12%) subjects died in the derivation and validation cohorts, respectively. In external validation, the machine learning model had an area under the receiver-operator curve of 0.82 (0.78–0.87) for prediction of 1-year all-cause mortality following hospital discharge after TAVI, which was superior to pre- and peri-procedural clinical variables including age 0.52 (0.46–0.59) and the EuroSCORE II 0.57 (0.51–0.64), P < 0.001 for a difference. Conclusion Machine learning based on readily available clinical data allows accurate prediction of 1-year all-cause mortality following a successful TAVI.

Funder

National Science Centre

Foundation for Polish Science

British Heart Foundation

National Heart, Lung, and Blood Institute

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Health Policy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3